Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nucleus Genomics
Minneapolis, Minnesota, United Statesmynucleus.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Nucleus Genomics offers direct-to-consumer clinical-grade whole-genome sequencing with advanced analytics. Their test provides deep analysis of risks for over 800 diseases using both rare variant detection and polygenic scores. The company integrates environmental/lifestyle data and updates results as new research emerges. They have CLIA certification and CAP accreditation for their lab operations. Recent features include an "AI Doctor" interface that delivers personalized recommendations based on genomics plus wearable device data. The company has raised $31.6M to date from top-tier investors.
- Therapeutic areas
- Other
- Modalities
- DNA testing (Whole-genome sequencing)Polygenic risk scoringAI-based health data analysisPharmacogenomics (planned/announced)
- Industry
- Molecular Diagnostics
02
Partnerships
Bionic HealthLegacySteadyMD network of doctors/genetic counselorsOfficial DNA partner of Bryan Johnson's Don’t Die Summit
Beyond the preview
Go deeper on Nucleus Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nucleus Genomics.